Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04979143 · ClinicalTrials.gov registry record · NA
Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient
A NA study, sponsored by University of Kansas Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT04979143 is a NA study that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 19 participants.
The verdict
NCT04979143, a NA study, was terminated before completion, sponsored by University of Kansas Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
To determine if use of Moses 2.0 results in improved ablation efficiency during holmium laser vaporization of the prostate. To determine if use of Moses 2.0 results in less char, improved visibility, and improved hemostasis in prostate vaporization.
Interventions
- PROCEDURE Surgical Approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2022-11-28 |
| Est. Completion | 2025-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04979143
The ClinicalTrials.gov registry entry for NCT04979143 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Surgical Approach is the first listed.
NCT04979143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04979143 about?
NCT04979143 is a clinical study titled "Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient". To determine if use of Moses 2.0 results in improved ablation efficiency during holmium laser vaporization of the prostate. To determine if use of Moses 2.0 results in less char, improved visibility, and improved hemostasis in prostate vaporization.
What is the current status of trial NCT04979143?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2022-11-28. Estimated completion is 2025-07-07.
What interventions are being tested in trial NCT04979143?
The interventions under investigation include: Surgical Approach (PROCEDURE).
Who is sponsoring clinical trial NCT04979143?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.